Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China · Delayed Price · Currency is CNY 69.18
-0.90 (-1.28%)
Sep 29, 2025, 2:45 PM CST
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 460.98 billion as of September 29, 2025. Its market cap has increased by 65.14% in one year.
Market Cap
460.98B
Enterprise Value
425.41B
Revenue
30.15B
Ranking
n/a
PE Ratio
59.63
Stock Price
69.18
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.58B to 460.98B, an increase of 17,791.35%. That is a compound annual growth rate of 23.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 460.98B | 57.95% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | 591.75B | 53.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 299.68B |
| Shenzhen Mindray Bio-Medical Electronics | 288.50B |
| Sichuan Biokin Pharmaceutical | 149.53B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.01B |
| Shanghai United Imaging Healthcare | 118.35B |
| Aier Eye Hospital Group | 114.80B |
| Yunnan Baiyao Group Co.,Ltd | 101.90B |
| Shanghai Fosun Pharmaceutical (Group) | 73.61B |